Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-21-008655

Options or other derivatives

  • Chief Clinical Dev. Officer acquired 27,213 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pano Arian · Chief Clinical Dev. Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-02 Grant or award : show line 1 in the form Share Option +23,325 23,325 D
2021-09-02 Grant or award : show line 2 in the form Restricted Share Units +3,888 3,888 D
Loading xslF345X03/edgar.xml…